Companies: 10,795·Total market cap: $144.5T
Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc.

MISTNASDAQHealthcare● Active
$1.23
+$0.00(+0.00%)
Market Cap$105643332
P/E Ratio
52W High$3.06
52W Low$1
Overview

Milestone Pharmaceuticals Inc. (MIST) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · MIST · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.68mist eps ttm · mist earnings per shareEarnings history
PE Ratio (TTM)mist pe ratio ttm · mist price to earningsPE Ratio deep dive
Revenue (TTM)$1.8Mmist revenue ttm · mist annual revenueFull revenue history
Dividend YieldNo Dividenddoes mist pay dividends · mist dividend yieldDividend history
Shares Outstanding83.9Mmist shares outstanding · mist floatShares outstanding history
Next EarningsAug 12, 2026Est.mist earnings date · mist next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$1.5M
202320242025
milestone pharmaceuticals inc. revenue · mist revenue 2025
FY 2025Net Income-$63.1M▼ 51.88% YoY
202320242025
milestone pharmaceuticals inc. net income · mist profit 2025
FY 2025EPS$-0.75▼ 11.94% YoY
202320242025
mist eps · milestone pharmaceuticals inc. earnings per share 2025
TTM:Revenue: $1.8MNet Income: -$68.4MEPS: $-0.68View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy7 analystsis mist a buy · mist analyst rating
Strong Buy
0
Buy
6
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$6.00Low
$1.23Current
$7.33Avg Target495.93% upside
$8.00High
mist price target · mist 12 month forecast

Total: 7 · Buy rate: 85.7%

The MIST analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $7.33, representing +495.93% upside from the current price of $1.23.

Stock Performance

Full History
1D+0.00%
1W-8.21%
1M-35.94%
3M-22.15%
YTD-39.11%
1Y-29.71%
5Y-77.05%

About Milestone Pharmaceuticals Inc.

CEOJoseph G. Oliveto
IPO DateMay 9, 2019
Employees33
CountryCA

Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in Montréal, Canada, specializing in the creation and commercialization of cardiovascular therapeutics. Their flagship product, etri…

what is milestone pharmaceuticals inc. · mist stock overview · milestone pharmaceuticals inc. company profile · who is milestone pharmaceuticals inc. ceo · mist NASDAQ · milestone pharmaceuticals inc. headquarters · milestone pharmaceuticals inc. business segments

About Stock Overview & Key Data

Milestone Pharmaceuticals Inc. (MIST) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 9, 2019. As of the latest trading session, MIST stock price is $1.23, with a market capitalization of $105.6M. The stock has returned -29.71% over the past 12 months and -39.11% year-to-date.

According to 7 Wall Street analysts, the consensus rating for Milestone Pharmaceuticals Inc. stock is Buy, with an average 12-month price target of $7.33. In fiscal year 2025, Milestone Pharmaceuticals Inc. reported revenue of $1.5M and net income of -$63.1M. For detailed data — including Milestone Pharmaceuticals Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Milestone Pharmaceuticals Inc. (MIST) stock price is $1.23. The stock is traded on NASDAQ under the ticker symbol MIST. The 52-week range is $1.00 – $3.06.

MIST stock priceMIST quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice